Protein Engineering Market By Reports And Data
Protein Engineering Market
To Reach USD 4.77 Billion By
2027
www.reportsanddata.com
Market
STheu incrmeasinmg reseaarcrh iyn protein engineering and rising government funding for new drug discovery are expected to be
some major drivers for the market.
Market Size – USD 1.86 Billion in 2019, Market Growth – CAGR of 12.3%, Market Trends– The growing research institutions
across developing economies is expected to fuel the market in the forecast period.
According to the current analysis of Reports and Data, the Protein Engineering market was valued at USD 1.86 billion in 2019
and is expected to reach USD 4.77 billion by the year 2027, at a CAGR of 12.3%. Protein engineering is the process of conception
and production of unnatural polypeptides, which is achieved through the modification of different amino acid sequences that
are found in nature. With the wide application of protein engineering, various synthetic protein structures and functions can
now be designed completely using a computer and produced in the laboratory using various methods.
With the advent of technology, the rising demand is expected to provide traction to the market. For instance, Computational
protein design holds a potential promise to revolutionize protein engineering. Protein engineering is significantly in demand as it
can develop useful or valuable proteins. It is known to be an emerging research field that helps researchers in understanding the
protein folding and recognition used for protein design principles. Protein engineering market is triggered owing to various
reasons such as availability of immense information regarding 3D protein structure, advancement in structural bioinformatics,
novel protein design algorithms, and other factors that have made it successfully possible to use computational approaches for
research and development in protein engineering.
www.reportsanddata.com
Market
Strategic utilization of approaches that have been discovered with research has enabled better
Sstaubilitmy andm increaaserd ycatalytic activity of the protein. Moreover, it has increased its applicability in
various fields that will further expand the market. Protein engineering has also evolved to become
a potent tool contributing considerably to the developments in both synthetic biology and
metabolic engineering. The rising funding for synthetic biology by the government and other
healthcare institutions may drive the industry extensively in the future. Furthermore, the
substantial ongoing research in the drug discovery process that finds treatments and cure for
various diseases in nature is expected to fuel the market widely in the forecast period. The growing
technological advancements and innovative instruments useful for protein engineering may drive
the market extensively in the future. Also, the emergence of new diseases due to microorganisms
may also trigger the market widely in the future.
Further key findings from the report suggest-
• Various collaborations are expected to fuel the industry growth and is known to have anticipated
the market growth. For instance, in 2019, Agilent Technologies acquired BioTek Instruments. The
merger allowed Agilent to establish itself in the immunotherapy and immune-oncology
segments and strengthen its position.
• Innovations in the protein engineering industry has contributed to the high growth of the
industry. For instance, in March 2020, scientists from the Unites States and Taiwan introduced a
new protein based on the sonification which was made using machine learning technique.
Avail the inside scoop of the Sample report @ https://
www.reportsanddata.com/sample-enquiry-form/3369
www.reportsanddata.com
Market
Summary
Companies considered and profiled in this market study
Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, Bio-Rad Laboratories, Bruker Corporation, GE
Healthcare, Waters Corporation, Sigma-Aldrich Corporation, Genscripts USA, Inc. and Perkinelmer, Inc.
For the purpose of this report, Reports and Data has segmented the Protein Engineering market on the basis of
product, type, technology, end use and region:
By Product Outlook (Revenue in Million USD; 2017-2027)
• Instruments
• Consumables
• Software & Services
By Type Outlook (Revenue in Million USD; 2017-2027)
• Monoclonal Antibodies
• Erythropoietin
• Interferons
• Vaccines
• Colony-stimulating Factors
• Growth Hormones
• Coagulation Factors
• Others
www.reportsanddata.com
Market
Summary
By Technology Outlook (Revenue in Million USD; 2017–2027)
• Rational Protein Design
• Irrational Protein Design
By End Use Outlook (Revenue in Million USD; 2017–2027)
• Biopharmaceutical Companies
• Contract Research Organizations
• Academic Research Institutes
Regional Outlook (Revenue in USD Million; 2016–2026)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa (MEA)
Download Summary: https://www.reportsanddata.com/download-summary-form/3369
www.reportsanddata.com
About Us
Reports and Data is a market research and
consulting company that provides syndicated research
reports, customized research reports, and consulting
services. Our solutions purely focus on your purpose to
locate, target and analyze consumer behavior shifts Contact US
across demographics, across industries and help client’s
make a smarter business decision.
John Watson
We offer market intelligence studies ensuring relevant Head of Business Development
and fact-based research across a multiple industries Reports And Data | Web:
including Healthcare, Technology, Chemicals, Power, and www.reportsanddata.com
Energy. We consistently update our research offerings Direct Line: +1-212-710-1370
to ensure our clients are aware about the latest trends E-mail: [email protected]
existent in the market. Reports and Data has a strong
base of experienced analysts from varied areas of
expertise.
www.reportsanddata.com
Comments